FDA's Robert Califf on AI in Healthcare: 'It's a Different World'

Healthcare executives at CES 2024 discussed AI's transformative impact on healthcare delivery. FDA Commissioner Robert Califf emphasized continuous AI assessment, acknowledging its profound influence. Leaders like Sara Vaezy and Lee Schwamm highlighted AI's potential in addressing industry challenges but stressed patient data protection. The dynamic CES environment showcased AI applications, from smart health tech to wearables, addressing administrative burdens and improving patient care. Califf foresees AI's pivotal role in homes, operating rooms, and clinics, shaping care management. The acceleration of adaptive AI models, like ChatGPT, heralds a paradigm shift, making algorithms fundamental in our daily lives.